Leerink reiterates 'outperform' on GoodRx after CEO hints at TrumpRx tie-up

GoodRx Holdings

01/10/2025 22:10

** Leerink Partners reiterates "outperform" rating on telehealth firm GoodRx GDRX.O

** GoodRx CEO Wendy Barnes mentioned on live television a potential partnership with TrumpRx, a recently announced program in conjunction with Pfizer PFE.N, to offer drugs directly, through cash pay, on a direct-to-consumer website

** "While there has not yet been any official reporting on this from either the White House or GoodRx, the stock spiked significantly following the interview" — Leerink Partners

** Brokerage adds "GDRX is certainly a logical technology platform for a program like TrumpRx to drive pricing transparency on a user-friendly website/mobile app"

** Co has partnered with Kroger's KR.N healthcare unit to expand its prescription savings services for branded drugs, including Novo Nordisk's NOVOb.CO popular weight-loss drug Wegovy

** Leerink Partners says "a potential partnership with GDRX and a government program such as TrumpRx would be additive to growth and a logical use of commercial technology to establish a transparency platform"

** As of last close, GDRX stock up 8.2% YTD

(Reporting by Siddhi Mahatole)

((siddhi.mahatole@thomsonreuters.com))